ZYME Max Pain
The max pain for Zymeworks Inc (ZYME) options expiring Nov 20, 2026 (7 DTE) is $30.00.
ZYME Max Pain by Expiry
The Max Pain for all expiration dates of ZYME.
| Expiration | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Nov 20, 2026 7 DTE monthly | 30.00 | 3.74 (14.24%) |
| Dec 18, 2026 35 DTE monthly | 17.50 | -8.76 (-33.36%) |
| Jan 15, 2027 63 DTE monthly | 30.00 | 3.74 (14.24%) |
| Apr 16, 2027 154 DTE monthly | 30.00 | 3.74 (14.24%) |
| Dec 17, 2027 399 DTE monthly | 30.00 | 3.74 (14.24%) |
ZYME Max Pain FAQ
What is max pain?
Max pain is the price where the total value of all open calls and puts would be lowest at expiration, so option buyers as a group would lose the most. Some traders watch it as a level the stock may drift toward near expiration, because option sellers, often market makers, hedge their positions in ways that can pull the price toward heavily traded strikes. It is a theory, not a guarantee.
What is ZYME max pain this week?
As of the Nov 12, 2026 close, max pain for Zymeworks options expiring Nov 20, 2026 is $30.00. The chart above shows the exact max pain for each expiration date.
Does ZYME trade above or below its max pain?
Zymeworks closed above its near-term max pain on 11 of the last 20 trading days. On Nov 12, 2026 it closed at $26.47, 11.8% below max pain of $30.00.
How has ZYME max pain changed recently?
Over the last 20 trading days, near-term max pain for Zymeworks ranged from $24.36 to $30.00. It went from $25.00 on Oct 16, 2026 to $30.00 on Nov 12, 2026. See the ZYME max pain history for a longer view.
What is Zymeworks Inc?
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics.